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In order to colonize a niche and compete for scarce resources, microorganisms have evolved means to adjust
the expression levels of their biosynthetic enzymes in response to the changing levels of metabolites available
to them. To do so, they often rely on transcription factors or structured RNAs that directly sense the
concentration of metabolites and turn genes on or off accordingly. In some instances, however, a metabolite
can be sensed by an actively translating ribosome bearing a nascent polypeptide whose specific amino acid
sequence interferes with translation. These “arrest peptides” lead to the formation of stalled ribosome nascent
chain complexes on the mRNA that can regulate the expression of downstream genes through transcriptional
or translational mechanisms. Although this process was discovered over three and a half decades ago, the
extent to which arrest peptides regulate gene expression in response to cell metabolites is unknown. Here, we
examine the physical constraints imposed by the ribosome on peptide-mediated ligand sensing and review
attempts to assess the diversity of arrest peptides to date. In addition, we outline a possible way forward to
establish how pervasive metabolite sensing by arrest peptides is in nature.
© 2016 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND license
(http://creativecommons.org/licenses/by-nc-nd/4.0/).Introduction
Bacterial metabolism is a complex, highly regulat-
ed process, in which a myriad of small molecules is
either imported from the surroundings into the cell, or
synthesized from basic precursors. In order to
maintain constant levels of metabolites inside their
cytoplasm, bacteria often rely on feedback loops,
such that the expression of key enzymes or
transporters is regulated by the end products of the
corresponding metabolic pathway. This enables
bacteria to adapt rapidly to changing environmental
conditions by directing limited resources to where
they are needed the most. For this to work, bacteria
must not only be able to sense the concentration of
specific metabolites, but should also possess
mechanisms that turn gene expression on or off in
response to these small molecules.Authors. Published by Elsevier Ltd. This
rg/licenses/by-nc-nd/4.0/).This perspective focuses on a form of regulation of
gene expression known as nascent chain-mediated
translational arrest, which takes place when a
partially synthesized “arrest peptide” pauses or
halts its own translation by interacting with the
polypeptide exit tunnel of the ribosome [1–3]. Arrest
can occur during the elongation phase of translation
by inhibiting peptide bond formation or during
termination by preventing peptide release from the
ribosome. Such process depends primarily upon the
amino acid sequence of the arrest peptide but often
requires the direct sensing of a small molecule by
the ribosomal exit tunnel containing the newly
synthesized nascent chain. Ribosomes that trans-
late arrest sequences in the presence of inducing
concentrations of such ligands become trapped on
the mRNA as inactive ribosome-nascent chain
complexes (RNC), which, in turn, regulate theis an open access article under the CC BY-NC-ND license
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Fig. 1. The ribosomal exit tunnel and metabolites sensed by arrest peptides. (a) Different regions of the ribosomal exit
tunnel and the various biological processes that take place within them, including (1) peptide bond formation, (2) translation
inhibition mediated by ribosome-targeting antibiotics or (3) antimicrobial peptides, (4) nascent chain-mediated translational
arrest, and (5) secondary or (6) tertiary structure formation. The nascent polypeptide inside the ribosomal exit tunnel is shown
in red. (b) Metabolites and drugs that are known to induce nascent chain-mediated translational arrest. Of these, only
tryptophan and erythromycin have been shown to directly interact with the nascent peptide.
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transcriptional or translational machineries. Since
ligand recognition by an RNC is mechanistically
distinct from the processes that regulate gene
expression once a ribosome has stalled on the
mRNA, we will only be dealing with the sensing
event here.
Although the existence of arrest peptides was
postulated more than 35 years ago [4,5] and their
involvement in several metabolic processes is well
documented, the extent to which they are able to
sense different types of small molecules in nature is
largely unknown. In order to address this issue, we
will begin by discussing how the physical constraints
imposed by the ribosome could shape ligand
recognition by arrest peptides. We will then review
previous attempts to measure the incidence and
diversity of arrest peptides and highlight the benefits
and limitations of the existing methods. Since this
perspective is forward looking, we will propose one
possible approach to reveal how pervasive nascent
chain-mediated translational arrest is as a form of
metabolic gene regulation.Three and a Half Decades of Arrest
Peptides
The notion that a translating ribosome might be
able to detect a small molecule was proposed as
early as 1980 by the Weisblum [5] and Dubnau [4]
laboratories. Both groups discovered that a short
leader region coding for a 19-aa peptide is needed to
induce the expression of the macrolide antibiotic
resistance gene ermC in response to sublethal
concentrations of the antibiotic erythromycin, and
that regulation is exerted at a post-transcriptional
level. A model was therefore proposed, whereby
ribosomes translating the leader peptide ErmCL stall
in the presence of erythromycin, thus altering the
conformation of the mRNA immediately upstream of
ermC and inducing its expression [4,5]. Drug-
dependent ribosome stalling was later proven to be
the key determinant for this new form of translational
control [6], and similar mechanisms were proposed
for the regulation of other genes that confer
resistance against macrolide antibiotics [7] or
against the peptidyl transferase inhibitor chloram-
phenicol [8].
Although one might argue that these peptides are
not true metabolite sensors given that the drug can
bind to the ribosome in the absence of a nascent
chain, these studies showed for the first time that a
ribosome could integrate signals encoded in the
amino acid sequence of a nascent peptide and in the
structure of a small ligand to alter its activity. The
discovery of other arrest peptides that could either
sense metabolites or cause stalling on their own
extended over the course of the next three decades.Seminal work by the Yanofsky group revealed that
stalled RNCs containing the TnaC peptide regulate
tryptophan catabolism in γ-proteobacteria, such as
Escherichia coli, by sensing the intracellular con-
centration of this amino acid [9]. Processes involving
the sensing of cell metabolites by arrested RNCs
were also discovered in eukaryotes and include the
arginine attenuator peptide [10], CGS1 [11], and a
peptide encoded by the AdoMet-DC upstream open
reading frame [12]. Some bacterial regulatory
peptides, such as SecM [13], MifM [14], and VemP
[15], are capable of triggering translational arrest on
their own but are beyond the scope of this
perspective.Physical Constraints Imposed by the
Ribosome on Metabolite-Sensing Arrest
Peptides
Arrest peptides operate within the confined envi-
ronment of the ribosomal exit tunnel, a long cavity
spanning the large subunit of the ribosome, through
which nascent peptides must transit in order to reach
the intracellular milieu (Fig. 1a) [16,17]. The exit
tunnel is approximately 100 Å in length, with a
diameter between 10 and 20 Å, and can be broadly
divided into three sectors [18]: (i) the upper/central
tunnel that contains the peptidyl transferase center
and the tunnel constriction formed by the extensions
of ribosomal proteins L22 and L4 in bacteria, where
several classes of antibiotics [19,20], natural antimi-
crobial peptides [21–23], and all arrest peptides
characterized to date exert their effects [1]; (ii) the
lower tunnel where the nascent peptide may begin to
acquire its secondary structure [18,24,25]; and (iii)
the vestibule where small elements of tertiary
structure may form before the nascent peptide
exits the ribosome [26,27]. Despite the generally
high degree of conservation of the upper/central
section, the exit tunnels of ribosomes from different
species, kingdoms, or even organelles can display
significant variations in their sequence and structure
[28]. As a result, arrest peptides may be specific for
organisms that are phylogenetically not too distantly
related [1,14], even though several of them are also
known to induce translational arrest on ribosomes
from other species [2].
The range of ligands currently known to induce
nascent chain-mediated translational arrest in bac-
teria or in eukaryotes includes amino acids [9,10]
and their derivatives [11], polyamines [12,29], and
antibiotics that target the large subunit of the
ribosome [6,8] (Fig. 1b). So far, only two of these
have been shown to interact directly with arrest
peptides inside the ribosomal exit tunnel (erythro-
mycin and L-tryptophan), although it is likely that this
holds true for other ligands as well. While there
2220 Perspective: Metabolite Sensing by Arrest Peptidesappears to be a marked preference for ligands with
delocalized electron systems that offer the possibility
of π-stacking (L-tryptophan, L-arginine, S-adenosyl-
methionine, chloramphenicol) or large hydrophobic
surfaces that provide an extended interaction sur-
face (erythromycin and other antibiotics from the
macrolide family), no obvious restrictions are appar-
ent in terms of their chemical composition. Given that
a nascent polypeptide occupies a large fraction of
the volume available within the exit tunnel, it is likely
that the size of a ligand will restrict its ability to
coexist with an arrest peptide present inside this
confined environment. Nevertheless, even large
molecules like erythromycin (N700 Da) are known
to interact with the nascent peptide in the upper/
central region of the tunnel and trigger peptide-
mediated arrest [30–32].
Structural information on the process of nascent
chain-mediated translational arrest comes exclu-
sively from the analysis of stalled RNCs by
cryo-electron microscopy [30,31,33–37], with the
highest resolutions of 3.8 Å, 3.9 Å, and 3.3–3.7 Å
reported to date for arrested TnaC–70S [35],
ErmCL–70S [30], and SecM–70S [37] complexes,
respectively. While this level of detail is sufficient to
show that arrest peptides generally inhibit the
ribosome by tampering with the geometry of the
peptidyl transferase center, the current resolution
precludes a detailed analysis of the intermolecular
contacts between the arrest peptide, its ligand, the
ribosome and ordered ions or solvent molecules.
Nevertheless, the location of ligand molecules within
arrested RNCs is either known or inferred for two
biological processes: (i) erythromycin-dependent
stalling of ribosomes translating the ErmBL [31] or
ErmCL [30] leader peptides, which results in the
activation of downstream genes whose products
confer resistance to macrolide antibiotics; and
(ii) translational arrest by the TnaC leader peptide
in response to elevated levels of L-tryptophan inside
the cell, which leads to the induction of the
tryptophanase operon in γ-proteobacteria [35]. In
both instances, the ligands bind deep within the
upper/central tunnel, where they are completely
surrounded by the ribosome and the arrest peptide.
Whether all functional groups from the ligand are
recognized is not clear at present, but there appears
to be a certain degree of structural plasticity at play.
Indeed, it is known that TnaC-dependent arrest can
be induced by a tryptophan analog [38] and that the
erythromycin-derivatives oleandomycin and azithro-
mycin can both trigger ErmBL-dependent transla-
tional arrest [31].
From the structures of stalled ErmBL/CL [30,31]
and TnaC [35] RNCs available to date, it appears
that ligand binding may take place at different stages
during the synthesis of the nascent peptide. In the
case of the ErmBL–70S [31] and ErmCL–70S [30]
complexes, the binding of erythromycin to the exittunnel is known to occur in the absence of the
nascent peptide, and the conformation of the drug
inside the ErmBL/CL-arrested RNCs is nearly
identical to that seen in a non-translating ribosome
[39,40]. Given the high affinity of erythromycin for the
large ribosomal subunit, this indicates that the
binding of the drug to the ribosome most likely
precedes the assembly of the translation initiation
complex on the mRNA and that the drug-obstructed
tunnel merely provides a new surface with which the
tRNA-linked nascent peptide can interact. On the
other hand, it has been suggested that binding sites
for two molecules of L-tryptophan are created when
the N-terminal portion of the nascent TnaC peptide
makes specific contacts with the ribosome at the
tunnel constriction [35]. These initial interactions
could cause a slowdown in the rate of polypeptide
egress through the tunnel, which, coupled to the
continued synthesis of the TnaC peptide at the
peptidyl transferase center, would lead to a com-
paction of the nascent chain to form the first
L-tryptophan binding site. This, in turn, could create
a binding site higher in the tunnel for a second
molecule of L-tryptophan, whose binding would
ultimately result in translational arrest. However,
additional evidence is needed to test this kinetic
model and the interaction of two tryptophan mole-
cules with the nascent TnaC peptide still needs to be
confirmed experimentally using other techniques.
How one or more ligand molecules might reach
their binding sites in RNCs such as the TnaC–70S
complex is unclear at this point. One possibility is
that these molecules are already present within
small hydrophobic cavities that line the exit tunnel
prior to the arrival of the nascent peptide. This would
be in agreement with the suggestion that certain
regions of the exit tunnel are thought to have a
marked propensity for interacting with small mole-
cules, including amino acids [41]. These regions
include the tunnel constriction or the crevice where
an incoming aminoacyl moiety binds following
accommodation of a tRNA into the A-site, as
suggested by the structures of numerous antibiotics
and several antimicrobial peptides bound to the
ribosome [21,23]. Another possibility is that trypto-
phan molecules enter the tunnel through the A-site
left vacant between each elongation cycle and reach
their binding pockets as soon as these are formed by
the elongating peptide. However, the rotational
dynamics and dielectric behavior of water inside
the exit tunnel differ from those of bulk solvent,
resulting in lowered solvent diffusion rates that could
render this latter approach more difficult [42].
Diffusion rates inside the tunnel may thus also be
important in determining the types of ligands that can
be sensed by RNCs.
To summarize, the available biochemical and
structural data give us no reason to believe that the
types of ligands sensed by arrest peptides should be
Fig. 2. Current methods for identifying arrest sequences. Genetic selection methods developed by Buskirk and
coworkers based on the (a) kanRΔ18 [45] or (b) HIS3 [46] selection markers. Note that both methods depend on the
rescue of stalled ribosomes by the tmRNA/SmpB system of E. coli. (c) The ribosome profiling technique, where deep
sequencing of nuclease-protected mRNA fragments (ribosome footprints) reveals the position of each ribosome with
nucleotide resolution [43]. (d) iNP [44] can detect and classify different translation intermediates through the comparative
electrophoretic analysis of 35S-Met pulse-labeled translation products left untreated, digested with RNase or treated with
the antibiotic puromycin. These translation intermediates are indicative of paused or stalled ribosomes.
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their size allows them to coexist with the nascent
peptide inside the ribosomal exit tunnel. The
question is whether this apparent lack of restrictions
also holds true in nature. As we shall see, the few
techniques available to identify arrest peptides,
although very elegant, are limited in their scope.
We therefore still lack the necessary tools to
systematically tackle this problem on a larger scale.Current Methods for the Identification of
Arrest Peptides
Experimental techniques for the identification of
nascent peptides that block the ribosome fall into two
categories. Methods involving genetic selection rely
on the expression of random DNA libraries fused to
reporter genes inside a bacterial host, such that the
identification of arrest sequences is achieved by
establishing a direct link between cell survival and
the stalling of an RNC on the mRNA. Approaches
based on profiling include the widely used ribosome
profiling technique to identify naturally occurring
peptide sequences that induce ribosome stalling
[43], as well as the recently published integrated in
vivo/vitro nascent chain profiling (iNP) technique,
which directly monitors pauses in translation on the
basis of peptidyl-tRNA profiles [44]. These last two
techniques have revealed that translation undergoes
frequent pausing, which, unexpectedly, cannot be
explained by codon usage alone.
Genetic selection approaches
Two methods have been developed that feature a
selection protocol based on the rescue of stalled
RNCs by the tmRNA/SmpB system [45,46]. This
ribonucleoprotein complex normally releases bacte-
rial ribosomes that have become trapped on a
non-stop mRNA and adds an SsrA tag [(A)ANDE-
NYALAA] to the C terminus of the nascent peptide to
target it for degradation. For this to occur, the mRNA
on which the stalled RNC is located must be trimmed
up to the site of stalling by various intracellular
ribonucleases, thus freeing the A-site for the tmRNA
complex. As we shall see shortly, this detail is
significant when selecting for arrest peptides.
The first method that relies on the tmRNA/SmpB
system makes use of a plasmid-encoded DNA
library in which a C-terminally truncated kanamycin
resistance gene (kanR) has six random codons
fused to its end [45] (Fig. 2a). Expression of the kanR
gene inside a bacterial host leads to the formation of
stalled RNCs when these last few codons encode an
arrest peptide. Stalled RNCs are then rescued by a
modified tmRNA that adds the remainder of the
KanR sequence instead of a degradation tag to the
nascent polypeptide, resulting in the expression of afunctional protein and cell survival in the presence of
kanamycin. Three classes of arrest peptides were
identified using this approach: (i) sequences encod-
ing C-terminal proline residues, which are now
known to cause particular problems for peptide
bond formation on the ribosome [47–49]; (ii) peptides
with an amino acid sequence resembling that of the
arrest peptide SecM; and (iii) the novel stalling
sequence FXXYXIWPP, which combines C-terminal
prolines with additional N-terminal residues to
induce strong translational arrest, both in vivo and
in vitro. It should be noted, however, that many of the
selected sequences triggered rescue by the tmRNA/
SmpB system for reasons other than peptide-
mediated arrest (i.e. stable mRNA secondary struc-
tures or rare codons).
Given that arrest sequences that inactivate the
KanR protein or feature more than 6 aa would
have been missed by the above method, a second
methodwasdeveloped that uses bacterial cells, which
cannot synthesize the amino acid histidine unless a
HIS3 gene is activated [46] (Fig. 2b). This gene is
transcribed from a weak promoter and its expression
is dependent on the active recruitment of RNA
polymerase to an operator located upstream of HIS3
by the DNA-binding protein cl. A random sequence of
20 codons was fused to the C terminus of the
full-length cl protein, thus ensuring that its structure
and function remain unaltered. Ribosomes undergo-
ing arrest during translation of this random sequence
become targets for the tmRNA/SmpB system, which
adds amodified SsrA tag [(A)ANDENYALDD] to theC
terminus of cl before releasing it into the cytosol.
Tagged cl then binds to its operator upstream of the
HIS3 promoter and recruits, via its SsrA tag, a fusion
between SspB and RNA polymerase to activate
transcription of HIS3. Importantly, the cI protein
featuring amutated tag is not targeted for degradation.
As a result, only those cells carrying a plasmid-en-
coded ribosome arrest sequence can grow on
selective medium lacking histidine. The relatively
high survival rate following selection (1/10,000 cells)
made it possible to identify and subsequently validate
20 sequences that did not match common arrest
motifs, such as poly-Pro or Pro-Stop.
Although the methods described above have led to
the identification of novel arrest peptides that operate
within an in vivo context, they have some limitations
that restrict their general applicability. One of these is
their reliance on the tmRNA/SmpB system, which
means that only stalling events that are released by
tmRNA/SmpB can be detected. However, it is known
that arrest peptides such as TnaC or SecM are not
substrates for tmRNA/SmpB [50,51], which requires a
vacant and fully functional A-site to operate. Given that
many arrest peptides are known to block the A-site at
the peptidyl transferase center (as shown by increased
resistance to the A-site substrate mimic puromycin
[9,52,53] and by structural studies [30,31,35–37]), it
2223Perspective: Metabolite Sensing by Arrest Peptidesappears likely that a large fraction of arrest peptides will
yield stalled RNCs that are impervious to the tmRNA/
SmpB system. Using these methods to identify arrest
peptides that sense small molecules is further compli-
cated by the fact that the molecule of interest must be
able to reach the ribosomes inside the cytoplasm.
Problems such as small molecule uptake, efflux, or
degradation are likely to be encountered with many of
the ligands one might like to test.
Profiling approaches
While the issue of small molecule availability will
remain problematic for any method carried out in
vivo, issues associated with the tmRNA/SmpB
system can be overcome through the use of
ribosome profiling, a high-throughput method for
obtaining information on the position of all translating
ribosomes on the mRNA at nucleotide resolution
[43]. According to this technique, an outstanding
readout along an mRNA molecule indicates ribo-
somal pausing at this position (Fig. 2c). Recent work
employing ribosome profiling has led to the identifi-
cation of peptide sequences that cause arrest in the
presence of macrolide antibiotics in the gram-
negative bacterium E. coli (erythromycin and teli-
thromycin) [54] and in the gram-positive bacterium
Staphylococcus aureus (azithromycin) [55]. As the
macrolide-sensing Erm peptides carry an arrest
motif close to their N terminus, high ribosome
densities were expected near the 5′ ends of
mRNAs. An increased appearance of arrested
ribosomes in this region was indeed observed in
the presence of erythromycin, but not in cells treated
with telithromycin or azithromycin. Instead, these
ligands caused ribosomal arrest at various locations
over the entire mRNA coding regions, in particular at
sites that were rich in prolines and charged residues.
The most prevalent arrest sequence identified in
both organisms is (R/K)x(R/K), which is highly similar
to the RLR motif found within the erythromycin-
dependent arrest peptide ErmDL. Sequences that
caused arrest in the presence of telithromycin in E.
coli could, in most cases, be further simplified to
[+]x[+], whereas sequences that triggered arrest in
response to azithromycin in S. aureus tended to
contain the motif x[+]x. Put together, these results
indicate that the nature of the amino acid residues at
the peptidyl transferase center is more important for
stalling than of those in close proximity to the
tunnel-bound drugs. Moreover, they highlight the
importance of ribosome profiling as a tool to study
drug-dependent translational arrest, which is in great
part due to the ubiquity of macrolide-specific arrest
motifs within the genome. Unfortunately, ribosome
profiling is not a practical way of identifying rare
stalling events, in particular when cells need to be
grown under specific conditions to observe arrest on
a single mRNA.Ribosome profiling is a powerful technique for the
study of translational arrest, but it is unable to detect
nascent polypeptides and can only monitor the
speed of translation indirectly. In contrast, the recent
iNP technique [44] is able to directly observe
transient translation intermediates by taking advan-
tage of the fact that partially synthesized polypep-
tides are covalently attached to a tRNA molecule
and can thus be distinguished from the correspond-
ing free peptides by SDS-PAGE at neutral pH
(Fig. 2d). Expression of a given polypeptide in vivo
or in vitro following a brief pulse of 35S-L-methionine
leads to the appearance of a number of radiolabelled
peptidyl-tRNA intermediates. These can be treated
with ribonuclease A or puromycin to release the
peptide moiety prior to analysis by neutral
SDS-PAGE, thereby making it possible to simulta-
neously detect translation intermediates and deter-
mine the extent to which they affect the peptidyl
transferase activity of the ribosome.
Using iNP, the nascent chain profiles of 1038 E.
coli proteins could be established, corresponding to
nearly a quarter of the known proteome for this
bacterium [44]. This monumental task confirmed that
translational pauses are widespread in nature and
revealed that these events can be classified into
various categories depending on their puromycin
sensitivity profiles. In particular, most of the pauses
detected were transient and much weaker compared
to translational arrest induced by SecM, with a
significant fraction being caused by consecutive
proline residues. While the iNP method appears to
be sufficiently robust to detect stalling and pausing
events, it remains to be seen whether it can be
automated to the point where it becomes practical to
use for the identification of new metabolite-
dependent arrest peptides.
To summarize, the methods available to date have
successfully identified novel arrest sequences but
have thus far not permitted us to discover the full
breadth of arrest processes that are likely to be
found in nature. The identification of a particular
ligand as the main determinant for arrest from the
large pool of metabolites inside the cell remains
problematic, as is the need for a target ligand to be
actively accumulated into the cells prior to selection.A Possible Way Forward
Monitoring the amino acid sequence of a peptide
that is undergoing translation is a fundamental
property of the ribosome and the last decade has
yielded significant structural and biochemical insights
into this process. Nevertheless, this unique property is
also one of the least understood aspects of ribosome
biology and the rules that dictate which nascent amino
acid sequences trigger translational arrest are only
just beginning to be elucidated. Despite the fact that
Fig. 3. Strategy to assess the generality and natural occurrence of metabolite-sensing arrest peptides. (a) Inverse
toeprinting makes it possible to precisely determine the location of an RNC on the mRNA while preserving its entire coding
region. This will make it possible to use inverse toeprinting as a tool to (b) select arrest peptides that are translated in vitro
from a pool of random DNA templates in the presence of a given metabolite (thus making it possible to discover new arrest
motifs), or to (c) identify naturally occurring arrest sequences encoded in bacterial genomes by performing high-throughput
parallel screens against a metabolite library.
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lational arrest have been reported, their serendipitous
discovery suggests that arrest peptides with specific-
ities for many other small molecules exist. Indeed, the
translation of upstream open reading frames present
in the leader regions of bacterial transcripts or in the
5′-untranslated regions of eukaryotic mRNAs is much
more pervasive than previously thought, and com-
bined computational and experimental strategies areunder way to evaluate their coding potential [56,57].
As a result, the coming years should see many new
arrestmotifs emerge from these growing collections of
mostly uncharacterized small ORFs.
Significantly, the bacterial ribosome is the target for
more than half of all antibiotics used today, many of
which inactivate it by binding to the peptidyl transfer-
ase center or the exit tunnel [19,20]. With bacterial
pathogens becoming increasingly resistant to existing
2225Perspective: Metabolite Sensing by Arrest Peptidesdrugs and fewer antibiotics entering the market every
year, the need for understanding the functional
diversity and mechanisms of action of arrest peptides
is ever more pressing [58]. Work by our group and
others recently showed that antimicrobial peptides
produced by the host immune response of insects and
mammals are potent inhibitors of protein synthesis
that block translation at the level of initiation in bacteria
[21–23]. These natural compounds target the same
regions of the ribosome as arrest peptides, indicating
that the latter could help steer the search for new,
improved antimicrobials.
For the field to move forward, it will be necessary to
establish how widespread nascent chain-mediated
translational arrest is and to determine the extent to
which arrest peptides act as metabolite sensors in
nature. Doing so will require us to identify the amino
acid sequences and structural features that determine
whether a nascent peptide passes through the exit
tunnel unhindered or induces translational arrest.
Biochemical and structural analyses of the type
carried out to date will obviously continue to yield
valuable insights to this end, but new techniques will
be needed to tackle these issues on a larger scale.
Known arrest peptides are short and only a few
conserved amino acids within a ~15 residue stretch
appear to be sufficient to induce translational arrest.
As a result, the bioinformatics-driven prediction of
arrest peptides is hindered by their small size, as
open reading frames shorter than 100 codons are
normally not considered in genome annotations [59],
and peptides encoded by short ORFs do not have
the same conserved patterns of secondary or tertiary
structure observed in larger proteins [56]. Thus,
computational approaches for the identification of
novel arrest peptides are currently limited to the
comparative analysis of ribosome profiling data [60].
Despite some limitations, experimental approaches
conceived thus far have shown that the detection of
novel arrest sequences lies within our reach. We
therefore propose that new high-throughput methods
combining the advantages of genetic selection and
ribosome profiling approaches will be key to revealing
the range and complexity of small molecules that can
be sensed by arrest peptides. To this end, we have
developed inverse toeprinting, a technique that
precisely maps the position of an arrested ribosome
on the mRNA, while protecting the entire coding
sequence up to the point of stalling (Fig. 3a, to be
published). This is in contrast with ribosome profiling
[43], which only generates a short footprint and thus
loses sequence information for most of the coding
region, or classical toeprinting (also known as primer
extension analysis [61]), which can accurately deter-
mine the position of the ribosome on the mRNA, but
cannot be used on a large scale. Inverse toeprinting
makes use of a highly processive 3′ → 5′ RNA
exonuclease that degrades the mRNA at a fixed
position downstream from the P-site codon in thestalled RNC. This allows the position of a stalled RNC
to be determined on the mRNA with codon resolution
while ensuring that the entire peptide-encoding region
can be analyzed by deep sequencing. Inverse
toeprinting is at the heart of our efforts to develop
both (i) an in vitro procedure for selecting metaboli-
te-sensing arrest sequences encoded in a random
DNA library (Fig. 3b), and (ii) an integrated pipeline for
the identification of naturally occurring arrest se-
quences encoded by a library of fragmented bacterial
genomic DNA (Fig. 3c). These techniques, we
believe, will be key to answering the question
formulated in the title and will take us closer to
deciphering the arrest code underlying nascent
chain-mediated translational arrest.
During the review process for this perspective, a
novel high-throughput approach to identify ribo-re-
gulatory elements in the 5’ UTRs of bacterial genes
was published [62]. This method, known as term--
seq, provides a quantitative snapshot of free 3’
mRNA termini present within a cell at a given time.
By carrying out term-seq in the presence or absence
of various metabolites, the authors observed pre-
mature transcription termination events that were
dependent on these molecules. Applying term-seq to
bacteria from different phyla, they could identify both
known and novel regulatory elements, including
some that are likely to involve arrest peptides.Acknowledgments
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